Abonnement à la biblothèque: Guest
Critical Reviews™ in Neurobiology

Publication de 3  numéros par an

ISSN Imprimer: 0892-0915

ISSN En ligne: 2375-0014

SJR: 0.121

Cannabinoids and Reward: Interactions with the Opioid System

Volume 16, Numéro 1&2, 2004, pp. 147-158
DOI: 10.1615/CritRevNeurobiol.v16.i12.160
Get accessGet access

RÉSUMÉ

There is currently substantial evidence that Cannabis sativa derivates act on brain reward in a way very similar to other drugs of abuse and exert numerous pharmacological effects through their interaction with various neurotransmitters and neuromodulators. Among them, the endogenous opioids seem to play an important role in modulating the addictive properties of cannabinoids. Given the plethora of research activity on such a topic, this brief review is necessarily focused on cannabinoid/opioid interaction in reward-related events and restricted to the recent literature. Recent findings from our and other laboratories concerning cannabinoid reinforcing effects as revealed by behavioral animal models of addiction are here summarized. Evidence is then provided demonstrating a functional cross-talk between the cannabinoid and opioid systems in the mutual modulation of the addictive behavior; accordingly, very recent data from transgenic mice lacking either the cannabinoid CB1 or opioid receptors are also presented. Finally, the role of the endogenous cannabinoid system in relapse to opioids is investigated by means of extinction/reinstatement animal models following a period, even prolonged, of drug abstinence. Altogether, the reviewed studies provided a better understanding of the neurobiological mechanisms involved in cannabinoid actions and revealed a bidirectional interaction between the endogenous cannabinoid and opioid systems in reward that extends to central mechanisms underlying relapsing phenomena. Challenges for the future involve elucidation of the neuroanatomical substrates of cannabinoids action, even in light of the therapeutic potential of these compounds.

CITÉ PAR
  1. Capasso R, Borrelli F, Cascio M G, Aviello G, Huben K, Zjawiony J K, Marini P, Romano B, Di Marzo V, Capasso F, Izzo A A, Inhibitory effect of salvinorin A, from Salvia divinorum , on ileitis-induced hypermotility: cross-talk between κ-opioid and cannabinoid CB1 receptors, British Journal of Pharmacology, 155, 5, 2008. Crossref

  2. Ständer Sonja, Weisshaar Elke, Luger Thomas A., Neurophysiological and neurochemical basis of modern pruritus treatment, Experimental Dermatology, 17, 3, 2008. Crossref

  3. Viveros M. P., Llorente R., Moreno E., Marco E. M., Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods, Behavioural Pharmacology, 16, 5-6, 2005. Crossref

  4. Cota Daniela, Woods Stephen C, The role of the endocannabinoid system in the regulation of energy homeostasis, Current Opinion in Endocrinology & Diabetes, 12, 5, 2005. Crossref

  5. Pinsger Martin, Schimetta Wolfgang, Volc Dieter, Hiermann Erich, Riederer Franz, Pölz Werner, Nutzen einer Add-On-Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit chronischen Schmerzzuständen – eine randomisierte kontrollierte Studie, Wiener klinische Wochenschrift, 118, 11-12, 2006. Crossref

  6. Xi Zheng-Xiong, Spiller Krista, Pak Arlene C, Gilbert Jeremy, Dillon Christopher, Li Xia, Peng Xiao-Qing, Gardner Eliot L, Cannabinoid CB1 Receptor Antagonists Attenuate Cocaine's Rewarding Effects: Experiments with Self-Administration and Brain-Stimulation Reward in Rats, Neuropsychopharmacology, 33, 7, 2008. Crossref

  7. Lile Joshua A., Kelly Thomas H., Pinsky David J., Hays Lon R., Substitution profile of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Δ9-tetrahydrocannabinol, Psychopharmacology, 203, 2, 2009. Crossref

  8. Fadda Paola, Scherma Maria, Spano Maria Sabrina, Salis Paola, Melis Valeria, Fattore Liana, Fratta Walter, Cannabinoid self-administration increases dopamine release in the nucleus accumbens, NeuroReport, 17, 15, 2006. Crossref

  9. Fattore L, Spano MS, Altea S, Fadda P, Fratta W, Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones, British Journal of Pharmacology, 160, 3, 2010. Crossref

  10. Fattore Liana, Viganò Daniela, Fadda Paola, Rubino Tiziana, Fratta Walter, Parolaro Daniela, Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2, European Journal of Neuroscience, 25, 7, 2007. Crossref

  11. Cota Daniela, CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health, Diabetes/Metabolism Research and Reviews, 23, 7, 2007. Crossref

  12. Caillé Stéphanie, Parsons Loren H, Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway, Neuropsychopharmacology, 31, 4, 2006. Crossref

  13. Ikoma Akihiko, Steinhoff Martin, Ständer Sonja, Yosipovitch Gil, Schmelz Martin, The neurobiology of itch, Nature Reviews Neuroscience, 7, 7, 2006. Crossref

  14. Taslimi Zahra, Haghparast Abbas, Hassanpour-Ezatti Majid, Safari Mir-Shahram, Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: Involvement of OX1 and CB1 receptors in the ventral tegmental area, Behavioural Brain Research, 217, 1, 2011. Crossref

  15. Zarrindast Mohammad-Reza, Nouri Maryam, Ahmadi Shamseddin, Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP, Brain Research, 1163, 2007. Crossref

  16. John Matthias, Appetite Stimulants, in Pharmacotherapy of Cachexia, 2005. Crossref

  17. Spano M. Sabrina, Ellgren Maria, Wang X., Hurd Yasmin L., Prenatal Cannabis Exposure Increases Heroin Seeking with Allostatic Changes in Limbic Enkephalin Systems in Adulthood, Biological Psychiatry, 61, 4, 2007. Crossref

  18. Fattore L., Fadda P., Spano M.S., Pistis M., Fratta W., Neurobiological mechanisms of cannabinoid addiction, Molecular and Cellular Endocrinology, 286, 1-2, 2008. Crossref

  19. Ziółkowska Barbara, Stefański Roman, Mierzejewski Paweł, Zapart Grzegorz, Kostowski Wojciech, Przewłocki Ryszard, Contingency does not contribute to the effects of cocaine self-administration on prodynorphin and proenkephalin gene expression in the rat forebrain, Brain Research, 1069, 1, 2006. Crossref

  20. Fattore Liana, Spano M. Sabrina, Deiana Serena, Melis Valeria, Cossu Gregorio, Fadda Paola, Fratta Walter, An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives, Brain Research Reviews, 53, 1, 2007. Crossref

  21. Deiana Serena, Fattore Liana, Sabrina Spano M., Cossu Gregorio, Porcu Emanuele, Fadda Paola, Fratta Walter, Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats, Neuropharmacology, 52, 2, 2007. Crossref

  22. Fattore Liana, Spano Sabrina, Cossu Gregorio, Deiana Serena, Fadda Paola, Fratta Walter, Cannabinoid CB1 antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats, Neuropharmacology, 48, 8, 2005. Crossref

  23. Roth-Deri Ilana, Green-Sadan Tamar, Yadid Gal, β-Endorphin and drug-induced reward and reinforcement, Progress in Neurobiology, 86, 1, 2008. Crossref

  24. Maldonado R., Berrendero F., Ozaita A., Robledo P., Neurochemical basis of cannabis addiction, Neuroscience, 181, 2011. Crossref

  25. Fattore Liana, Altea Silvia, Fratta Walter, Sex Differences in Drug Addiction: A Review of Animal and Human Studies, Women's Health, 4, 1, 2008. Crossref

  26. Richard Denis, Guesdon Benjamin, Timofeeva Elena, The brain endocannabinoid system in the regulation of energy balance, Best Practice & Research Clinical Endocrinology & Metabolism, 23, 1, 2009. Crossref

  27. López Hassan H., Webb Sarah A., Nash Sean, Cannabinoid receptor antagonism increases female sexual motivation, Pharmacology Biochemistry and Behavior, 92, 1, 2009. Crossref

  28. Fattore L, Spano MS, Melis V, Fadda P, Fratta W, Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats, British Journal of Pharmacology, 163, 7, 2011. Crossref

  29. Coleman John J., Bensinger Peter B., Gold Mark S., Smith David E., Bianchi Robert P., DuPont Robert L., Can Drug Design Inhibit Abuse?, Journal of Psychoactive Drugs, 37, 4, 2005. Crossref

  30. Bodnar Richard J., Klein Gad E., Endogenous opiates and behavior: 2004, Peptides, 26, 12, 2005. Crossref

  31. Di Marzo Vincenzo, Bisogno Tiziana, De Petrocellis Luciano, Endocannabinoids and Related Compounds: Walking Back and Forth between Plant Natural Products and Animal Physiology, Chemistry & Biology, 14, 7, 2007. Crossref

  32. Solecki Wojciech, Ziolkowska Barbara, Krowka Tomasz, Gieryk Agnieszka, Filip Malgorzata, Przewlocki Ryszard, Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration, Brain Research, 1255, 2009. Crossref

  33. Benedetti Fabrizio, Thoen Wilma, Blanchard Catherine, Vighetti Sergio, Arduino Claudia, Pain as a reward: Changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems, Pain, 154, 3, 2013. Crossref

  34. Richard Denis, Timofeeva Elena, Energy Balance Regulation, in Obesity Prevention, 2010. Crossref

  35. Ranganathan Mohini, Carbuto Michelle, Braley Gabriel, Elander Jaqueline, Perry Edward, Pittman Brian, Radhakrishnan Rajiv, Sewell Richard A., D'Souza Deepak C., Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans, The International Journal of Neuropsychopharmacology, 15, 09, 2012. Crossref

  36. Scavone J.L., Sterling R.C., Van Bockstaele E.J., Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal, Neuroscience, 248, 2013. Crossref

  37. Karimi Sara, Azizi Pegah, Shamsizadeh Ali, Haghparast Abbas, Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference, Behavioural Brain Research, 247, 2013. Crossref

  38. Rashidy-Pour Ali, Pahlevani Pouyan, Vaziri Anoumid, Shaigani Pariya, Zarepour Leila, Vafaei Abbas Ali, Haghparast Abbas, Involvement of CB1 receptors in the ventral tegmental area in the potentiation of morphine rewarding properties in acquisition but not expression in the conditioned place preference model, Behavioural Brain Research, 247, 2013. Crossref

  39. Coria Santiago M., Roura-Martínez David, Ucha Marcos, Assis María Amparo, Miguéns Miguel, García-Lecumberri Carmen, Higuera-Matas Alejandro, Ambrosio Emilio, Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 53, 2014. Crossref

  40. Chang Sulie L., Connaghan Kaitlyn P., Wei Yufeng, Li Ming D., NeuroHIV and Use of Addictive Substances, in Neuroimmune Signaling in Drug Actions and Addictions, 118, 2014. Crossref

  41. Carlino Elisa, Frisaldi Elisa, Benedetti Fabrizio, Pain and the context, Nature Reviews Rheumatology, 10, 6, 2014. Crossref

  42. Haghparast Abbas, Shamsizadeh Ali, Samandari Razieh, Omranifard Alireza, Vaziri Anoumid, Razavi Yasaman, Cannabinoid receptors in the basolateral amygdala are involved in the potentiation of morphine rewarding properties in the acquisition, but not expression of conditioned place preference in rats, Brain Research, 1565, 2014. Crossref

  43. Panagis George, Mackey Brian, Vlachou Styliani, Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future, Frontiers in Psychiatry, 5, 2014. Crossref

  44. Fatahi Zahra, Assar Nasim, Mahmoudi Dorna, Pahlevani Pouyan, Moradi Marzieh, Haghparast Abbas, Functional interaction between the orexin-1 and CB1 receptors within the nucleus accumbens in the conditioned place preference induced by the lateral hypothalamus stimulation, Pharmacology Biochemistry and Behavior, 132, 2015. Crossref

  45. Vigorito Michael, Connaghan Kaitlyn P., Chang Sulie L., The HIV-1 transgenic rat model of neuroHIV, Brain, Behavior, and Immunity, 48, 2015. Crossref

  46. Ivanov Iliyan S., Schuiz Kurt P., Palmero Robyn C., Newcorn Jeffrey H., Neurorobiology and Evidence-Based Biological Treatments for Substance Abuse Disorders, CNS Spectrums, 11, 11, 2006. Crossref

  47. Blair Robert E., Deshpande Laxmikant S., DeLorenzo Robert J., Endocannabinoids and epilepsy, in Cannabinoids in Neurologic and Mental Disease, 2015. Crossref

  48. Yazdi Fatemeh, Jahangirvand Mahboubeh, Pirasteh Amir-Hossein, Moradi Marzieh, Haghparast Abbas, Functional interaction between OX2 and CB1 receptors in the ventral tegmental area and the nucleus accumbens in response to place preference induced by chemical stimulation of the lateral hypothalamus, Pharmacology Biochemistry and Behavior, 139, 2015. Crossref

  49. De Luca Maria Antonietta, Fattore Liana, Cannabinoids and drug addiction, in Cannabinoids in Neurologic and Mental Disease, 2015. Crossref

  50. Parsons Loren H., Hurd Yasmin L., Endocannabinoid signalling in reward and addiction, Nature Reviews Neuroscience, 16, 10, 2015. Crossref

  51. Shimoide A., Ilmi Yoon , Fuse M., Beale H.C., Singh R., Automated Behavioral Phenotype Detection and Analysis Using Color-Based Motion Tracking, The 2nd Canadian Conference on Computer and Robot Vision (CRV'05), 2005. Crossref

  52. Molaei Marzieh, Fatahi Zahra, Zaringhalam Jalal, Haghparast Abbas, CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens, Journal of Molecular Neuroscience, 58, 4, 2016. Crossref

  53. Panlilio L.V., Justinova Z., Trigo J.M., Le Foll B., Screening Medications for the Treatment of Cannabis Use Disorder, in Animal Models for Medications Screening to Treat Addiction, 126, 2016. Crossref

  54. Piper Brian J, DeKeuster Rebecca M, Beals Monica L, Cobb Catherine M, Burchman Corey A, Perkinson Leah, Lynn Shayne T, Nichols Stephanie D, Abess Alexander T, Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep, Journal of Psychopharmacology, 31, 5, 2017. Crossref

  55. Laredo Sarah A., Marrs William R., Parsons Loren H., Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology, in Endocannabinoids and Lipid Mediators in Brain Functions, 2017. Crossref

  56. Spanagel Rainer, Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior, Physiological Reviews, 89, 2, 2009. Crossref

  57. Chen Jingchun, Brunzell Darlene H., Jackson Kia, van der Vaart Andrew, Ma Jennie Z., Payne Thomas J., Sherva Richard, Farrer Lindsay A., Gejman Pablo, Levinson Douglas F., Holmans Peter, Aggen Steven H., Damaj Imad, Kuo Po-Hsiu, Webb Bradley T., Anton Raymond, Kranzler Henry R., Gelernter Joel, Li Ming D., Kendler Kenneth S., Chen Xiangning, Le Foll Bernard, ACSL6 Is Associated with the Number of Cigarettes Smoked and Its Expression Is Altered by Chronic Nicotine Exposure, PLoS ONE, 6, 12, 2011. Crossref

  58. Tirgar Fatemeh, Rezayof Ameneh, Alijanpour Sakineh, Yazdanbakhsh Nima, Interactive effects of morphine and nicotine on memory function depend on the central amygdala cannabinoid CB1 receptor function in rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 82, 2018. Crossref

  59. Sloan Matthew E., Gowin Joshua L., Ramchandani Vijay A., Hurd Yasmin L., Le Foll Bernard, The endocannabinoid system as a target for addiction treatment: Trials and tribulations, Neuropharmacology, 124, 2017. Crossref

  60. Ansonoff Michael A., Wen Ting, Pintar John E., Genetic Studies of Opioid System Function in Mice, in The Opiate Receptors, 2011. Crossref

  61. Ständer S., Luger T. A., Neuroreceptors and Mediators, in Neuroimmunology of the Skin, 2009. Crossref

  62. Woods Stephen C., Cota Daniela, Endocannabinoids and Energy Homeostasis, in Treatment of the Obese Patient, 2007. Crossref

  63. Lissoni Paolo, A Review of the Opioid System in Cancer Patients and Preliminary Results of Opioid Antagonists in the Treatment of Human Neoplasms, in Opiate Receptors and Antagonists, 2009. Crossref

  64. Mastinu Andrea, Premoli Marika, Ferrari-Toninelli Giulia, Tambaro Simone, Maccarinelli Giuseppina, Memo Maurizio, Bonini Sara Anna, Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation, Hormone Molecular Biology and Clinical Investigation, 36, 2, 2018. Crossref

  65. Cohen Koby, Weizman Abraham, Weinstein Aviv, Modulatory effects of cannabinoids on brain neurotransmission, European Journal of Neuroscience, 50, 3, 2019. Crossref

  66. Ballesta Antonio, Orio Laura, Arco Rocío, Vargas Antonio, Romero-Sanchiz Pablo, Nogueira-Arjona Raquel, de Heras Raquel Gómez, Antón María, Ramírez-López Mayte, Serrano Antonia, Pavón Francisco Javier, de Fonseca Fernando Rodríguez, Suárez Juan, Alen Francisco, Bupropion, a possible antidepressant without negative effects on alcohol relapse, European Neuropsychopharmacology, 29, 6, 2019. Crossref

  67. Ständer Sonja, Luger Thomas A., Neuroreceptors and Neuromediators, in Pruritus, 2010. Crossref

  68. Fattore Liana, Fadda Paola, Fratta Walter, Endocannabinoid regulation of relapse mechanisms, Pharmacological Research, 56, 5, 2007. Crossref

  69. Picone Robert P., Kendall Debra A., Minireview: From the Bench, Toward the Clinic: Therapeutic Opportunities for Cannabinoid Receptor Modulation, Molecular Endocrinology, 29, 6, 2015. Crossref

  70. Lucatch Aliya M., Kloiber Stefan M., Meyer Jeffrey H., Rizvi Sakina J., George Tony P., Effects of Extended Cannabis Abstinence in Major Depressive Disorder, Canadian Journal of Addiction, 11, 3, 2020. Crossref

  71. Mackie Ken, CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS, Annual Review of Pharmacology and Toxicology, 46, 1, 2006. Crossref

  72. Mohammadkhani Aida, Borgland Stephanie L., Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal, Journal of Neuroscience Research, 100, 1, 2022. Crossref

  73. Ahmed Mashal, Best Laura M., Pereira Christina F., Boileau Isabelle, Kloiber Stefan, Effects of endocannabinoid system modulation on social behaviour: A systematic review of animal studies, Neuroscience & Biobehavioral Reviews, 138, 2022. Crossref

  74. Brunt Tibor M., Bossong Matthijs G., Smith Yoland, The neuropharmacology of cannabinoid receptor ligands in central signaling pathways, European Journal of Neuroscience, 55, 4, 2022. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain